{"transactions":[{"id":307088,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14410,"kind":"person","name":"Garber Alan M","position":1,"cik":"0001312907","reported_name":"Garber Alan M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Deferred Stock Units","published_at":"2026-07-17T20:05:47.000Z","date":"2026-07-15","kind":"grant","planned":false,"acquired":true,"shares":31.56,"price":475.28,"value":14999.8368,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each deferred stock unit represents one share of common stock and is paid out in common stock upon the earliest to occur of (i) termination of Dr. Garber's service on our board of directors, (ii) a change of control of our company and (iii) Dr. Garber's disability or death."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each deferred stock unit represents one share of common stock and is paid out in common stock upon the earliest to occur of (i) termination of Dr. Garber's service on our board of directors, (ii) a change of control of our company and (iii) Dr. Garber's disability or death."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each deferred stock unit represents one share of common stock and is paid out in common stock upon the earliest to occur of (i) termination of Dr. Garber's service on our board of directors, (ii) a change of control of our company and (iii) Dr. Garber's disability or death."}],"balance_after":65.458,"derivative":{"underlying":"Common Stock","underlying_shares":31.56},"source":{"system":"sec-edgar","filing":"0000875320-26-000247","document":"wk-form4_1784318742.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532026000247/wk-form4_1784318742.xml","form_type":"4"}},{"id":310078,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14410,"kind":"person","name":"Garber Alan M","position":1,"cik":"0001312907","reported_name":"Garber Alan M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-05-05T20:58:47.000Z","date":"2026-05-01","kind":"grant","planned":false,"acquired":true,"shares":1433,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Fully vested."}],"balance_after":1433,"derivative":{"exercise_price":424.45,"expiration_date":"2036-04-30","underlying":"Common Stock","underlying_shares":1433},"source":{"system":"sec-edgar","filing":"0000875320-26-000179","document":"wk-form4_1778014724.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532026000179/wk-form4_1778014724.xml","form_type":"4"}},{"id":310077,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14410,"kind":"person","name":"Garber Alan M","position":1,"cik":"0001312907","reported_name":"Garber Alan M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-05-05T20:58:47.000Z","date":"2026-05-01","kind":"grant","planned":false,"acquired":true,"shares":472,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Restricted stock unit award that vests, subject to certain limited exceptions, on the first anniversary of the grant date."}],"balance_after":7344,"source":{"system":"sec-edgar","filing":"0000875320-26-000179","document":"wk-form4_1778014724.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532026000179/wk-form4_1778014724.xml","form_type":"4"}},{"id":310645,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14410,"kind":"person","name":"Garber Alan M","position":1,"cik":"0001312907","reported_name":"Garber Alan M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Deferred Stock Units","published_at":"2026-04-17T20:14:55.000Z","date":"2026-04-15","kind":"grant","planned":false,"acquired":true,"shares":33.898,"price":442.5,"value":14999.865,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each deferred stock unit represents one share of common stock and is paid out in common stock upon the earliest to occur of (i) termination of Dr. Garber's service on our board of directors, (ii) a change of control of our company and (iii) Dr. Garber's disability or death."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each deferred stock unit represents one share of common stock and is paid out in common stock upon the earliest to occur of (i) termination of Dr. Garber's service on our board of directors, (ii) a change of control of our company and (iii) Dr. Garber's disability or death."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each deferred stock unit represents one share of common stock and is paid out in common stock upon the earliest to occur of (i) termination of Dr. Garber's service on our board of directors, (ii) a change of control of our company and (iii) Dr. Garber's disability or death."}],"balance_after":33.898,"derivative":{"underlying":"Common Stock","underlying_shares":33.898},"source":{"system":"sec-edgar","filing":"0000875320-26-000159","document":"wk-form4_1776456893.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532026000159/wk-form4_1776456893.xml","form_type":"4"}},{"id":322561,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14410,"kind":"person","name":"Garber Alan M","position":1,"cik":"0001312907","reported_name":"Garber Alan M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-05-05T20:19:11.000Z","date":"2025-05-01","kind":"grant","planned":false,"acquired":true,"shares":1199,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Fully vested."}],"balance_after":1199,"derivative":{"exercise_price":502.97,"expiration_date":"2035-04-30","underlying":"Common Stock","underlying_shares":1199},"source":{"system":"sec-edgar","filing":"0000875320-25-000177","document":"wk-form4_1746476345.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532025000177/wk-form4_1746476345.xml","form_type":"4"}},{"id":322560,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14410,"kind":"person","name":"Garber Alan M","position":1,"cik":"0001312907","reported_name":"Garber Alan M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-05-05T20:19:11.000Z","date":"2025-05-01","kind":"grant","planned":false,"acquired":true,"shares":398,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Restricted stock unit award that vests, subject to certain limited exceptions, on the first anniversary of the grant date."}],"balance_after":6872,"source":{"system":"sec-edgar","filing":"0000875320-25-000177","document":"wk-form4_1746476345.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532025000177/wk-form4_1746476345.xml","form_type":"4"}},{"id":334165,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14410,"kind":"person","name":"Garber Alan M","position":1,"cik":"0001312907","reported_name":"Garber Alan M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-05-03T20:11:24.000Z","date":"2024-05-01","kind":"grant","planned":false,"acquired":true,"shares":3142,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Fully vested."}],"balance_after":3142,"derivative":{"exercise_price":399.71,"expiration_date":"2034-04-30","underlying":"Common Stock","underlying_shares":3142},"source":{"system":"sec-edgar","filing":"0000875320-24-000121","document":"wk-form4_1714767073.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532024000121/wk-form4_1714767073.xml","form_type":"4"}},{"id":1562429,"issuer":{"id":3386,"kind":"organization","name":"EXELIXIS, INC."},"owners":[{"id":14410,"kind":"person","name":"Garber Alan M","position":1,"cik":"0001312907","reported_name":"Garber Alan M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option (right to buy)","published_at":"2024-03-25T23:31:20.000Z","date":"2024-03-21","kind":"exercise","planned":true,"acquired":false,"shares":23491,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option, representing the right to purchase a total of 23,491 shares of Exelixis, Inc. common stock became fully exercisable on May 25, 2017."}],"balance_after":0,"derivative":{"exercise_price":19.57,"exercise_date":"2017-05-25","expiration_date":"2024-05-24","underlying":"Common Stock","underlying_shares":23491},"source":{"system":"sec-edgar","filing":"0000939767-24-000036","document":"wk-form4_1711409469.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/939767/000093976724000036/wk-form4_1711409469.xml","form_type":"4"}},{"id":1562428,"issuer":{"id":3386,"kind":"organization","name":"EXELIXIS, INC."},"owners":[{"id":14410,"kind":"person","name":"Garber Alan M","position":1,"cik":"0001312907","reported_name":"Garber Alan M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-03-25T23:31:20.000Z","date":"2024-03-21","kind":"sale","planned":true,"acquired":false,"shares":19205,"price":24.01,"value":461112.05,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 8, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $24.00 to $24.01. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 2 to this Form 4."}],"balance_after":35703,"source":{"system":"sec-edgar","filing":"0000939767-24-000036","document":"wk-form4_1711409469.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/939767/000093976724000036/wk-form4_1711409469.xml","form_type":"4"}},{"id":1562427,"issuer":{"id":3386,"kind":"organization","name":"EXELIXIS, INC."},"owners":[{"id":14410,"kind":"person","name":"Garber Alan M","position":1,"cik":"0001312907","reported_name":"Garber Alan M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-03-25T23:31:20.000Z","date":"2024-03-21","kind":"exercise","planned":true,"acquired":true,"shares":23491,"price":19.57,"value":459718.87,"ownership":{"direct":true},"balance_after":54908,"source":{"system":"sec-edgar","filing":"0000939767-24-000036","document":"wk-form4_1711409469.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/939767/000093976724000036/wk-form4_1711409469.xml","form_type":"4"}},{"id":1870853,"issuer":{"id":3386,"kind":"organization","name":"EXELIXIS, INC."},"owners":[{"id":14410,"kind":"person","name":"Garber Alan M","position":1,"cik":"0001312907","reported_name":"Garber Alan M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option (right to buy)","published_at":"2023-06-03T01:24:18.000Z","date":"2023-06-01","kind":"grant","planned":false,"acquired":true,"shares":44087,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Option granted pursuant to the Exelixis, Inc. 2017 Equity Incentive Plan. The option is exercisable immediately, subject to repurchase provisions, and will vest as to 100% of the shares subject to the option on the first anniversary of the date of grant, subject to the Reporting Person's continuous service through such date."}],"balance_after":44087,"derivative":{"exercise_price":19.39,"exercise_date":"2023-06-01","expiration_date":"2030-05-31","underlying":"Common Stock","underlying_shares":44087},"source":{"system":"sec-edgar","filing":"0000939767-23-000062","document":"wk-form4_1685755448.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/939767/000093976723000062/wk-form4_1685755448.xml","form_type":"4"}},{"id":349496,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14410,"kind":"person","name":"Garber Alan M","position":1,"cik":"0001312907","reported_name":"Garber Alan M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-05-03T20:52:27.000Z","date":"2023-05-01","kind":"grant","planned":false,"acquired":true,"shares":1741,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Fully vested."}],"balance_after":1741,"derivative":{"exercise_price":342.73,"expiration_date":"2033-04-30","underlying":"Common Stock","underlying_shares":1741},"source":{"system":"sec-edgar","filing":"0001209191-23-027015","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919123027015/doc4.xml","form_type":"4"}},{"id":349495,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14410,"kind":"person","name":"Garber Alan M","position":1,"cik":"0001312907","reported_name":"Garber Alan M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-05-03T20:52:27.000Z","date":"2023-05-01","kind":"grant","planned":false,"acquired":true,"shares":584,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Restricted stock unit award that vests, subject to certain limited exceptions, on the first anniversary of the grant date."}],"balance_after":6474,"source":{"system":"sec-edgar","filing":"0001209191-23-027015","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919123027015/doc4.xml","form_type":"4"}},{"id":1997032,"issuer":{"id":3386,"kind":"organization","name":"EXELIXIS, INC."},"owners":[{"id":14410,"kind":"person","name":"Garber Alan M","position":1,"cik":"0001312907","reported_name":"Garber Alan M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option (right to buy)","published_at":"2023-02-24T02:08:12.000Z","date":"2023-02-21","kind":"exercise","acquired":false,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option, representing the right to purchase a total of 40,000 shares of Exelixis, Inc. common stock, became fully exercisable on May 26, 2016."}],"balance_after":0,"derivative":{"exercise_price":6.3,"exercise_date":"2016-05-26","expiration_date":"2023-05-25","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0000939767-23-000028","document":"wf-form4_167720447178170.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/939767/000093976723000028/wf-form4_167720447178170.xml","form_type":"4"}},{"id":1997031,"issuer":{"id":3386,"kind":"organization","name":"EXELIXIS, INC."},"owners":[{"id":14410,"kind":"person","name":"Garber Alan M","position":1,"cik":"0001312907","reported_name":"Garber Alan M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-02-24T02:08:12.000Z","date":"2023-02-21","kind":"sale","acquired":false,"shares":40000,"price":17.49,"value":699600.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 2, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $17.39 to $17.55. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 2 to this Form 4."}],"balance_after":31417,"source":{"system":"sec-edgar","filing":"0000939767-23-000028","document":"wf-form4_167720447178170.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/939767/000093976723000028/wf-form4_167720447178170.xml","form_type":"4"}},{"id":1997030,"issuer":{"id":3386,"kind":"organization","name":"EXELIXIS, INC."},"owners":[{"id":14410,"kind":"person","name":"Garber Alan M","position":1,"cik":"0001312907","reported_name":"Garber Alan M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-02-24T02:08:12.000Z","date":"2023-02-21","kind":"exercise","acquired":true,"shares":40000,"price":6.3,"value":252000.0,"ownership":{"direct":true},"balance_after":71417,"source":{"system":"sec-edgar","filing":"0000939767-23-000028","document":"wf-form4_167720447178170.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/939767/000093976723000028/wf-form4_167720447178170.xml","form_type":"4"}},{"id":2254241,"issuer":{"id":3386,"kind":"organization","name":"EXELIXIS, INC."},"owners":[{"id":14410,"kind":"person","name":"Garber Alan M","position":1,"cik":"0001312907","reported_name":"Garber Alan M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option (right to buy)","published_at":"2022-05-28T00:15:24.000Z","date":"2022-05-26","kind":"grant","acquired":true,"shares":42422,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Option granted pursuant to the Exelixis, Inc. 2017 Equity Incentive Plan. The option is exercisable immediately, subject to repurchase provisions, and will vest as to 100% of the shares subject to the option on the first anniversary of the date of grant, subject to the Reporting Person's continuous service through such date."}],"balance_after":42422,"derivative":{"exercise_price":18.19,"exercise_date":"2022-05-26","expiration_date":"2029-05-25","underlying":"Common Stock","underlying_shares":42422},"source":{"system":"sec-edgar","filing":"0000939767-22-000073","document":"wf-form4_165369690559101.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/939767/000093976722000073/wf-form4_165369690559101.xml","form_type":"4"}},{"id":361996,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14410,"kind":"person","name":"Garber Alan M","position":1,"cik":"0001312907","reported_name":"Garber Alan M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-05-03T20:42:07.000Z","date":"2022-05-01","kind":"grant","acquired":true,"shares":4462,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":4462,"derivative":{"exercise_price":276.17,"exercise_date":"2022-05-01","expiration_date":"2032-04-30","underlying":"Common Stock","underlying_shares":4462},"source":{"system":"sec-edgar","filing":"0000899243-22-016329","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000089924322016329/doc4.xml","form_type":"4"}},{"id":2356730,"issuer":{"id":3386,"kind":"organization","name":"EXELIXIS, INC."},"owners":[{"id":14410,"kind":"person","name":"Garber Alan M","position":1,"cik":"0001312907","reported_name":"Garber Alan M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option (right to buy)","published_at":"2022-03-04T01:07:35.000Z","date":"2022-03-01","kind":"exercise","acquired":false,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option, representing the right to purchase a total of 40,000 shares of Exelixis, Inc. common stock, became fully exercisable on May 28, 2015."}],"balance_after":0,"derivative":{"exercise_price":3.13,"exercise_date":"2015-05-28","expiration_date":"2022-05-27","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0000939767-22-000034","document":"wf-form4_164635603258608.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/939767/000093976722000034/wf-form4_164635603258608.xml","form_type":"4"}},{"id":2356729,"issuer":{"id":3386,"kind":"organization","name":"EXELIXIS, INC."},"owners":[{"id":14410,"kind":"person","name":"Garber Alan M","position":1,"cik":"0001312907","reported_name":"Garber Alan M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-03-04T01:07:35.000Z","date":"2022-03-01","kind":"sale","acquired":false,"shares":21301,"price":21,"value":447321.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 4, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $21.00 to $21.01. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 2 to this Form 4."}],"balance_after":31417,"source":{"system":"sec-edgar","filing":"0000939767-22-000034","document":"wf-form4_164635603258608.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/939767/000093976722000034/wf-form4_164635603258608.xml","form_type":"4"}},{"id":2356728,"issuer":{"id":3386,"kind":"organization","name":"EXELIXIS, INC."},"owners":[{"id":14410,"kind":"person","name":"Garber Alan M","position":1,"cik":"0001312907","reported_name":"Garber Alan M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-03-04T01:07:35.000Z","date":"2022-03-01","kind":"exercise","acquired":true,"shares":40000,"price":3.13,"value":125200.0,"ownership":{"direct":true},"balance_after":52718,"source":{"system":"sec-edgar","filing":"0000939767-22-000034","document":"wf-form4_164635603258608.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/939767/000093976722000034/wf-form4_164635603258608.xml","form_type":"4"}},{"id":2691942,"issuer":{"id":3386,"kind":"organization","name":"EXELIXIS, INC."},"owners":[{"id":14410,"kind":"person","name":"Garber Alan M","position":1,"cik":"0001312907","reported_name":"Garber Alan M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option (right to buy)","published_at":"2021-05-29T00:17:02.000Z","date":"2021-05-27","kind":"grant","acquired":true,"shares":33549,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Option granted pursuant to the Exelixis, Inc. 2017 Equity Incentive Plan. The option is exercisable immediately, subject to repurchase provisions, and will vest as to 100% of the shares subject to the option on the first anniversary of the date of grant, subject to the Reporting Person's continuous service through such date."}],"balance_after":33549,"derivative":{"exercise_price":22.48,"exercise_date":"2021-05-27","expiration_date":"2028-05-26","underlying":"Common Stock","underlying_shares":33549},"source":{"system":"sec-edgar","filing":"0000939767-21-000060","document":"wf-form4_162224738849446.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/939767/000093976721000060/wf-form4_162224738849446.xml","form_type":"4"}},{"id":376079,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14410,"kind":"person","name":"Garber Alan M","position":1,"cik":"0001312907","reported_name":"Garber Alan M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-05-04T20:08:54.000Z","date":"2021-05-01","kind":"grant","acquired":true,"shares":6067,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Fully vested."}],"balance_after":6067,"derivative":{"exercise_price":217.2,"expiration_date":"2031-04-30","underlying":"Common Stock","underlying_shares":6067},"source":{"system":"sec-edgar","filing":"0001209191-21-029845","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919121029845/doc4.xml","form_type":"4"}},{"id":2783970,"issuer":{"id":3386,"kind":"organization","name":"EXELIXIS, INC."},"owners":[{"id":14410,"kind":"person","name":"Garber Alan M","position":1,"cik":"0001312907","reported_name":"Garber Alan M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option (right to buy)","published_at":"2021-03-18T00:11:08.000Z","date":"2021-03-15","kind":"exercise","acquired":false,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option, representing the right to purchase a total of 40,000 shares of Exelixis, Inc. common stock, became fully exercisable on May 29, 2014."}],"balance_after":0,"derivative":{"exercise_price":3.38,"exercise_date":"2014-05-29","expiration_date":"2021-05-28","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0000939767-21-000037","document":"wf-form4_161602625006192.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/939767/000093976721000037/wf-form4_161602625006192.xml","form_type":"4"}},{"id":2783969,"issuer":{"id":3386,"kind":"organization","name":"EXELIXIS, INC."},"owners":[{"id":14410,"kind":"person","name":"Garber Alan M","position":1,"cik":"0001312907","reported_name":"Garber Alan M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-03-18T00:11:08.000Z","date":"2021-03-15","kind":"sale","acquired":false,"shares":40000,"price":23.6,"value":944000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 25, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $23.09 to $23.74. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 2 to this Form 4."}],"balance_after":12718,"source":{"system":"sec-edgar","filing":"0000939767-21-000037","document":"wf-form4_161602625006192.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/939767/000093976721000037/wf-form4_161602625006192.xml","form_type":"4"}},{"id":2783968,"issuer":{"id":3386,"kind":"organization","name":"EXELIXIS, INC."},"owners":[{"id":14410,"kind":"person","name":"Garber Alan M","position":1,"cik":"0001312907","reported_name":"Garber Alan M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-03-18T00:11:08.000Z","date":"2021-03-15","kind":"exercise","acquired":true,"shares":40000,"price":3.38,"value":135200.0,"ownership":{"direct":true},"balance_after":52718,"source":{"system":"sec-edgar","filing":"0000939767-21-000037","document":"wf-form4_161602625006192.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/939767/000093976721000037/wf-form4_161602625006192.xml","form_type":"4"}},{"id":389776,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14410,"kind":"person","name":"Garber Alan M","position":1,"cik":"0001312907","reported_name":"Garber Alan M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-06-03T20:26:40.000Z","date":"2020-06-01","kind":"grant","acquired":true,"shares":2264,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Fully vested."}],"balance_after":2264,"derivative":{"exercise_price":286.27,"expiration_date":"2030-05-31","underlying":"Common Stock","underlying_shares":2264},"source":{"system":"sec-edgar","filing":"0001209191-20-034012","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919120034012/doc4.xml","form_type":"4"}},{"id":389775,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14410,"kind":"person","name":"Garber Alan M","position":1,"cik":"0001312907","reported_name":"Garber Alan M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-06-03T20:26:40.000Z","date":"2020-06-01","kind":"grant","acquired":true,"shares":699,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Restricted stock unit award that vests, subject to certain limited exceptions, on the first anniversary of the grant date."}],"balance_after":5890,"source":{"system":"sec-edgar","filing":"0001209191-20-034012","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919120034012/doc4.xml","form_type":"4"}},{"id":3137980,"issuer":{"id":3386,"kind":"organization","name":"EXELIXIS, INC."},"owners":[{"id":14410,"kind":"person","name":"Garber Alan M","position":1,"cik":"0001312907","reported_name":"Garber Alan M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option (right to buy)","published_at":"2020-05-23T00:53:41.000Z","date":"2020-05-21","kind":"grant","acquired":true,"shares":30750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Option granted pursuant to the Exelixis, Inc. 2017 Equity Incentive Plan. The option is exercisable immediately, subject to repurchase provisions, and will vest as to 100% of the shares subject to the option on the first anniversary of the date of grant, subject to the Reporting Person's continuous service through such date."}],"balance_after":30750,"derivative":{"exercise_price":24.62,"exercise_date":"2020-05-21","expiration_date":"2027-05-20","underlying":"Common Stock","underlying_shares":30750},"source":{"system":"sec-edgar","filing":"0000939767-20-000091","document":"wf-form4_159019520279217.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/939767/000093976720000091/wf-form4_159019520279217.xml","form_type":"4"}},{"id":3137979,"issuer":{"id":3386,"kind":"organization","name":"EXELIXIS, INC."},"owners":[{"id":14410,"kind":"person","name":"Garber Alan M","position":1,"cik":"0001312907","reported_name":"Garber Alan M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-05-23T00:53:41.000Z","date":"2020-05-22","kind":"sale","acquired":false,"shares":36111,"price":24.42,"value":881830.62,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 30, 2019."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $24.22 to $24.70. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 2 to this Form 4."}],"balance_after":12718,"source":{"system":"sec-edgar","filing":"0000939767-20-000091","document":"wf-form4_159019520279217.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/939767/000093976720000091/wf-form4_159019520279217.xml","form_type":"4"}},{"id":3271848,"issuer":{"id":3386,"kind":"organization","name":"EXELIXIS, INC."},"owners":[{"id":14410,"kind":"person","name":"Garber Alan M","position":1,"cik":"0001312907","reported_name":"Garber Alan M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-02-15T01:36:25.000Z","date":"2020-02-14","kind":"sale","acquired":false,"shares":12500,"price":21.02,"value":262750.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 30, 2019."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $21.00 to $21.03. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 2 to this Form 4."}],"balance_after":48829,"source":{"system":"sec-edgar","filing":"0000939767-20-000016","document":"wf-form4_158173056798179.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/939767/000093976720000016/wf-form4_158173056798179.xml","form_type":"4"}},{"id":3314700,"issuer":{"id":3386,"kind":"organization","name":"EXELIXIS, INC."},"owners":[{"id":14410,"kind":"person","name":"Garber Alan M","position":1,"cik":"0001312907","reported_name":"Garber Alan M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option (right to buy)","published_at":"2020-01-10T01:31:46.000Z","date":"2020-01-07","kind":"exercise","acquired":false,"shares":56956,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"The option, representing the right to purchase a total of 56,956 shares of Exelixis, Inc. common stock, became fully exercisable on December 6, 2013."}],"balance_after":0,"derivative":{"exercise_price":5.82,"exercise_date":"2013-12-06","expiration_date":"2020-12-05","underlying":"Common Stock","underlying_shares":56956},"source":{"system":"sec-edgar","filing":"0000939767-20-000003","document":"wf-form4_157861988780844.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/939767/000093976720000003/wf-form4_157861988780844.xml","form_type":"4"}},{"id":3314699,"issuer":{"id":3386,"kind":"organization","name":"EXELIXIS, INC."},"owners":[{"id":14410,"kind":"person","name":"Garber Alan M","position":1,"cik":"0001312907","reported_name":"Garber Alan M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option (right to buy)","published_at":"2020-01-10T01:31:46.000Z","date":"2020-01-07","kind":"exercise","acquired":false,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"The option, representing the right to purchase a total of 30,000 shares of Exelixis, Inc. common stock, became fully exercisable on May 23, 2013."}],"balance_after":0,"derivative":{"exercise_price":4.58,"exercise_date":"2013-05-23","expiration_date":"2020-05-22","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0000939767-20-000003","document":"wf-form4_157861988780844.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/939767/000093976720000003/wf-form4_157861988780844.xml","form_type":"4"}},{"id":3314698,"issuer":{"id":3386,"kind":"organization","name":"EXELIXIS, INC."},"owners":[{"id":14410,"kind":"person","name":"Garber Alan M","position":1,"cik":"0001312907","reported_name":"Garber Alan M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-01-10T01:31:46.000Z","date":"2020-01-07","kind":"sale","acquired":false,"shares":86956,"price":18.01,"value":1566077.56,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 30, 2019."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $18.00 to $18.02. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 2 to this Form 4."}],"balance_after":61329,"source":{"system":"sec-edgar","filing":"0000939767-20-000003","document":"wf-form4_157861988780844.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/939767/000093976720000003/wf-form4_157861988780844.xml","form_type":"4"}},{"id":3314697,"issuer":{"id":3386,"kind":"organization","name":"EXELIXIS, INC."},"owners":[{"id":14410,"kind":"person","name":"Garber Alan M","position":1,"cik":"0001312907","reported_name":"Garber Alan M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-01-10T01:31:46.000Z","date":"2020-01-07","kind":"exercise","acquired":true,"shares":56956,"price":5.82,"value":331483.92,"ownership":{"direct":true},"balance_after":148285,"source":{"system":"sec-edgar","filing":"0000939767-20-000003","document":"wf-form4_157861988780844.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/939767/000093976720000003/wf-form4_157861988780844.xml","form_type":"4"}},{"id":3314696,"issuer":{"id":3386,"kind":"organization","name":"EXELIXIS, INC."},"owners":[{"id":14410,"kind":"person","name":"Garber Alan M","position":1,"cik":"0001312907","reported_name":"Garber Alan M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-01-10T01:31:46.000Z","date":"2020-01-07","kind":"exercise","acquired":true,"shares":30000,"price":4.58,"value":137400.0,"ownership":{"direct":true},"balance_after":91329,"source":{"system":"sec-edgar","filing":"0000939767-20-000003","document":"wf-form4_157861988780844.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/939767/000093976720000003/wf-form4_157861988780844.xml","form_type":"4"}},{"id":402549,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14410,"kind":"person","name":"Garber Alan M","position":1,"cik":"0001312907","reported_name":"Garber Alan M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-06-04T20:10:32.000Z","date":"2019-06-01","kind":"grant","acquired":true,"shares":3330,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Fully vested."}],"balance_after":3330,"derivative":{"exercise_price":168.04,"expiration_date":"2029-05-31","underlying":"Common Stock","underlying_shares":3330},"source":{"system":"sec-edgar","filing":"0001209191-19-034223","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919119034223/doc4.xml","form_type":"4"}},{"id":402548,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14410,"kind":"person","name":"Garber Alan M","position":1,"cik":"0001312907","reported_name":"Garber Alan M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-06-04T20:10:32.000Z","date":"2019-06-01","kind":"grant","acquired":true,"shares":1191,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Restricted stock unit award that vests, subject to certain limited exceptions, on the first anniversary of the grant date."}],"balance_after":5191,"source":{"system":"sec-edgar","filing":"0001209191-19-034223","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919119034223/doc4.xml","form_type":"4"}},{"id":3512504,"issuer":{"id":3386,"kind":"organization","name":"EXELIXIS, INC."},"owners":[{"id":14410,"kind":"person","name":"Garber Alan M","position":1,"cik":"0001312907","reported_name":"Garber Alan M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option (right to buy)","published_at":"2019-05-25T00:45:13.000Z","date":"2019-05-23","kind":"grant","acquired":true,"shares":42641,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Option granted pursuant to the Exelixis, Inc. 2017 Equity Incentive Plan. The option is exercisable immediately, subject to repurchase provisions, and will vest as to 100% of the shares subject to the option on the first anniversary of the date of grant, subject to the Reporting Person's continuous service through such date."}],"balance_after":42641,"derivative":{"exercise_price":19.77,"exercise_date":"2019-05-23","expiration_date":"2026-05-22","underlying":"Common Stock","underlying_shares":42641},"source":{"system":"sec-edgar","filing":"0000939767-19-000135","document":"wf-form4_155874509766298.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/939767/000093976719000135/wf-form4_155874509766298.xml","form_type":"4"}},{"id":3566302,"issuer":{"id":3386,"kind":"organization","name":"EXELIXIS, INC."},"owners":[{"id":14410,"kind":"person","name":"Garber Alan M","position":1,"cik":"0001312907","reported_name":"Garber Alan M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option (right to buy)","published_at":"2019-04-03T23:58:45.000Z","date":"2019-04-01","kind":"sale","acquired":false,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option, representing the right to purchase a total of 15,000 shares of Exelixis, Inc. common stock, became fully exercisable on May 24, 2012."}],"balance_after":0,"derivative":{"exercise_price":4.57,"exercise_date":"2012-05-24","expiration_date":"2019-05-23","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0000939767-19-000078","document":"wf-form4_155433591000438.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/939767/000093976719000078/wf-form4_155433591000438.xml","form_type":"4"}},{"id":3566301,"issuer":{"id":3386,"kind":"organization","name":"EXELIXIS, INC."},"owners":[{"id":14410,"kind":"person","name":"Garber Alan M","position":1,"cik":"0001312907","reported_name":"Garber Alan M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option (right to buy)","published_at":"2019-04-03T23:58:45.000Z","date":"2019-04-01","kind":"sale","acquired":false,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option, representing the right to purchase a total of 15,000 shares of Exelixis, Inc. common stock, became fully exercisable on May 19, 2010."}],"balance_after":0,"derivative":{"exercise_price":5.92,"exercise_date":"2010-05-19","expiration_date":"2020-05-18","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0000939767-19-000078","document":"wf-form4_155433591000438.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/939767/000093976719000078/wf-form4_155433591000438.xml","form_type":"4"}},{"id":3566300,"issuer":{"id":3386,"kind":"organization","name":"EXELIXIS, INC."},"owners":[{"id":14410,"kind":"person","name":"Garber Alan M","position":1,"cik":"0001312907","reported_name":"Garber Alan M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-04-03T23:58:45.000Z","date":"2019-04-01","kind":"sale","acquired":false,"shares":15000,"price":23.97,"value":359550.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 30, 2018 and modified on February 28, 2019."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $23.89 to $24.14. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 2 to this Form 4."}],"balance_after":61329,"source":{"system":"sec-edgar","filing":"0000939767-19-000078","document":"wf-form4_155433591000438.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/939767/000093976719000078/wf-form4_155433591000438.xml","form_type":"4"}},{"id":3566299,"issuer":{"id":3386,"kind":"organization","name":"EXELIXIS, INC."},"owners":[{"id":14410,"kind":"person","name":"Garber Alan M","position":1,"cik":"0001312907","reported_name":"Garber Alan M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-04-03T23:58:45.000Z","date":"2019-04-01","kind":"exercise","acquired":true,"shares":15000,"price":4.57,"value":68550.0,"ownership":{"direct":true},"balance_after":76329,"source":{"system":"sec-edgar","filing":"0000939767-19-000078","document":"wf-form4_155433591000438.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/939767/000093976719000078/wf-form4_155433591000438.xml","form_type":"4"}},{"id":3566298,"issuer":{"id":3386,"kind":"organization","name":"EXELIXIS, INC."},"owners":[{"id":14410,"kind":"person","name":"Garber Alan M","position":1,"cik":"0001312907","reported_name":"Garber Alan M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-04-03T23:58:45.000Z","date":"2019-04-01","kind":"sale","acquired":false,"shares":15000,"price":24,"value":360000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 30, 2018 and modified on February 28, 2019."}],"balance_after":61329,"source":{"system":"sec-edgar","filing":"0000939767-19-000078","document":"wf-form4_155433591000438.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/939767/000093976719000078/wf-form4_155433591000438.xml","form_type":"4"}},{"id":3566297,"issuer":{"id":3386,"kind":"organization","name":"EXELIXIS, INC."},"owners":[{"id":14410,"kind":"person","name":"Garber Alan M","position":1,"cik":"0001312907","reported_name":"Garber Alan M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-04-03T23:58:45.000Z","date":"2019-04-01","kind":"exercise","acquired":true,"shares":15000,"price":5.92,"value":88800.0,"ownership":{"direct":true},"balance_after":76329,"source":{"system":"sec-edgar","filing":"0000939767-19-000078","document":"wf-form4_155433591000438.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/939767/000093976719000078/wf-form4_155433591000438.xml","form_type":"4"}},{"id":3699359,"issuer":{"id":3386,"kind":"organization","name":"EXELIXIS, INC."},"owners":[{"id":14410,"kind":"person","name":"Garber Alan M","position":1,"cik":"0001312907","reported_name":"Garber Alan M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option (right to buy)","published_at":"2019-01-10T00:47:49.000Z","date":"2019-01-08","kind":"exercise","acquired":false,"shares":11250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option, representing the right to purchase a total of 11,250 shares of Exelixis, Inc. common stock, became fully exercisable on May 14, 2010."}],"balance_after":0,"derivative":{"exercise_price":4.16,"exercise_date":"2010-05-14","expiration_date":"2019-05-13","underlying":"Common Stock","underlying_shares":11250},"source":{"system":"sec-edgar","filing":"0000939767-19-000009","document":"wf-form4_154708125252237.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/939767/000093976719000009/wf-form4_154708125252237.xml","form_type":"4"}},{"id":3699358,"issuer":{"id":3386,"kind":"organization","name":"EXELIXIS, INC."},"owners":[{"id":14410,"kind":"person","name":"Garber Alan M","position":1,"cik":"0001312907","reported_name":"Garber Alan M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-01-10T00:47:49.000Z","date":"2019-01-08","kind":"sale","acquired":false,"shares":11250,"price":23,"value":258750.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 30, 2018."}],"balance_after":61329,"source":{"system":"sec-edgar","filing":"0000939767-19-000009","document":"wf-form4_154708125252237.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/939767/000093976719000009/wf-form4_154708125252237.xml","form_type":"4"}},{"id":3699357,"issuer":{"id":3386,"kind":"organization","name":"EXELIXIS, INC."},"owners":[{"id":14410,"kind":"person","name":"Garber Alan M","position":1,"cik":"0001312907","reported_name":"Garber Alan M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-01-10T00:47:49.000Z","date":"2019-01-08","kind":"exercise","acquired":true,"shares":11250,"price":4.16,"value":46800.0,"ownership":{"direct":true},"balance_after":72579,"source":{"system":"sec-edgar","filing":"0000939767-19-000009","document":"wf-form4_154708125252237.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/939767/000093976719000009/wf-form4_154708125252237.xml","form_type":"4"}},{"id":414309,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14410,"kind":"person","name":"Garber Alan M","position":1,"cik":"0001312907","reported_name":"Garber Alan M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2018-06-05T21:13:00.000Z","date":"2018-06-01","kind":"grant","acquired":true,"shares":3229,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Fully vested."}],"balance_after":3229,"derivative":{"exercise_price":152.74,"expiration_date":"2028-05-31","underlying":"Common Stock","underlying_shares":3229},"source":{"system":"sec-edgar","filing":"0001209191-18-035796","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919118035796/doc4.xml","form_type":"4"}},{"id":414308,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14410,"kind":"person","name":"Garber Alan M","position":1,"cik":"0001312907","reported_name":"Garber Alan M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-06-05T21:13:00.000Z","date":"2018-06-01","kind":"grant","acquired":true,"shares":1801,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Restricted stock unit award that vests, subject to certain limited exceptions, on the first anniversary of the grant date."}],"balance_after":4000,"source":{"system":"sec-edgar","filing":"0001209191-18-035796","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919118035796/doc4.xml","form_type":"4"}},{"id":3919286,"issuer":{"id":3386,"kind":"organization","name":"EXELIXIS, INC."},"owners":[{"id":14410,"kind":"person","name":"Garber Alan M","position":1,"cik":"0001312907","reported_name":"Garber Alan M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option (right to buy)","published_at":"2018-05-25T00:20:37.000Z","date":"2018-05-24","kind":"grant","acquired":true,"shares":31167,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Option granted pursuant to the Exelixis, Inc. 2017 Equity Incentive Plan. The option is exercisable immediately, subject to repurchase provisions, and will vest as to 1/12th of the shares subject to the option each month following the date of grant, subject to the Reporting Person's continuous service through such dates."}],"balance_after":31167,"derivative":{"exercise_price":20.5,"exercise_date":"2018-05-24","expiration_date":"2025-05-23","underlying":"Common Stock","underlying_shares":31167},"source":{"system":"sec-edgar","filing":"0000939767-18-000103","document":"wf-form4_152720762288163.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/939767/000093976718000103/wf-form4_152720762288163.xml","form_type":"4"}},{"id":3961432,"issuer":{"id":3386,"kind":"organization","name":"EXELIXIS, INC."},"owners":[{"id":14410,"kind":"person","name":"Garber Alan M","position":1,"cik":"0001312907","reported_name":"Garber Alan M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option (right to buy)","published_at":"2018-04-19T00:11:14.000Z","date":"2018-04-16","kind":"exercise","acquired":false,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option, representing the right to purchase a total of 15,000 shares of Exelixis, Inc. common stock, became fully exercisable on May 19, 2011."}],"balance_after":0,"derivative":{"exercise_price":11.66,"exercise_date":"2011-05-19","expiration_date":"2018-05-18","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0000939767-18-000054","document":"wf-form4_152409666066391.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/939767/000093976718000054/wf-form4_152409666066391.xml","form_type":"4"}},{"id":3961431,"issuer":{"id":3386,"kind":"organization","name":"EXELIXIS, INC."},"owners":[{"id":14410,"kind":"person","name":"Garber Alan M","position":1,"cik":"0001312907","reported_name":"Garber Alan M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-04-19T00:11:14.000Z","date":"2018-04-16","kind":"sale","acquired":false,"shares":15000,"price":20.25,"value":303750.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 26, 2017."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $20.03 to $20.73. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 2 to this Form 4."}],"balance_after":61329,"source":{"system":"sec-edgar","filing":"0000939767-18-000054","document":"wf-form4_152409666066391.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/939767/000093976718000054/wf-form4_152409666066391.xml","form_type":"4"}},{"id":3961430,"issuer":{"id":3386,"kind":"organization","name":"EXELIXIS, INC."},"owners":[{"id":14410,"kind":"person","name":"Garber Alan M","position":1,"cik":"0001312907","reported_name":"Garber Alan M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-04-19T00:11:14.000Z","date":"2018-04-16","kind":"exercise","acquired":true,"shares":15000,"price":11.66,"value":174900.0,"ownership":{"direct":true},"balance_after":76329,"source":{"system":"sec-edgar","filing":"0000939767-18-000054","document":"wf-form4_152409666066391.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/939767/000093976718000054/wf-form4_152409666066391.xml","form_type":"4"}},{"id":4102341,"issuer":{"id":3386,"kind":"organization","name":"EXELIXIS, INC."},"owners":[{"id":14410,"kind":"person","name":"Garber Alan M","position":1,"cik":"0001312907","reported_name":"Garber Alan M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option (right to buy)","published_at":"2018-01-11T00:27:21.000Z","date":"2018-01-09","kind":"exercise","acquired":false,"shares":11500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option, representing the right to purchase a total of 15,000 shares of Exelixis, Inc. common stock, became fully exercisable on May 2, 2009."}],"balance_after":0,"derivative":{"exercise_price":7.97,"exercise_date":"2009-05-02","expiration_date":"2018-05-01","underlying":"Option (right to buy)","underlying_shares":11500},"source":{"system":"sec-edgar","filing":"0000939767-18-000002","document":"wf-form4_151563042764056.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/939767/000093976718000002/wf-form4_151563042764056.xml","form_type":"4"}},{"id":4102340,"issuer":{"id":3386,"kind":"organization","name":"EXELIXIS, INC."},"owners":[{"id":14410,"kind":"person","name":"Garber Alan M","position":1,"cik":"0001312907","reported_name":"Garber Alan M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option (right to buy)","published_at":"2018-01-11T00:27:21.000Z","date":"2018-01-08","kind":"exercise","acquired":false,"shares":3500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option, representing the right to purchase a total of 15,000 shares of Exelixis, Inc. common stock, became fully exercisable on May 2, 2009."}],"balance_after":11500,"derivative":{"exercise_price":7.97,"exercise_date":"2009-05-02","expiration_date":"2018-05-01","underlying":"Option (right to buy)","underlying_shares":3500},"source":{"system":"sec-edgar","filing":"0000939767-18-000002","document":"wf-form4_151563042764056.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/939767/000093976718000002/wf-form4_151563042764056.xml","form_type":"4"}},{"id":4102339,"issuer":{"id":3386,"kind":"organization","name":"EXELIXIS, INC."},"owners":[{"id":14410,"kind":"person","name":"Garber Alan M","position":1,"cik":"0001312907","reported_name":"Garber Alan M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-01-11T00:27:21.000Z","date":"2018-01-09","kind":"sale","acquired":false,"shares":11500,"price":30,"value":345000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 26, 2017."}],"balance_after":61329,"source":{"system":"sec-edgar","filing":"0000939767-18-000002","document":"wf-form4_151563042764056.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/939767/000093976718000002/wf-form4_151563042764056.xml","form_type":"4"}},{"id":4102338,"issuer":{"id":3386,"kind":"organization","name":"EXELIXIS, INC."},"owners":[{"id":14410,"kind":"person","name":"Garber Alan M","position":1,"cik":"0001312907","reported_name":"Garber Alan M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-01-11T00:27:21.000Z","date":"2018-01-09","kind":"exercise","acquired":true,"shares":11500,"price":7.97,"value":91655.0,"ownership":{"direct":true},"balance_after":72829,"source":{"system":"sec-edgar","filing":"0000939767-18-000002","document":"wf-form4_151563042764056.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/939767/000093976718000002/wf-form4_151563042764056.xml","form_type":"4"}},{"id":4102337,"issuer":{"id":3386,"kind":"organization","name":"EXELIXIS, INC."},"owners":[{"id":14410,"kind":"person","name":"Garber Alan M","position":1,"cik":"0001312907","reported_name":"Garber Alan M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-01-11T00:27:21.000Z","date":"2018-01-08","kind":"sale","acquired":false,"shares":3500,"price":31.29,"value":109515.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 26, 2017."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $31.00 to $31.51. Reporting person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 2 to this Form 4."}],"balance_after":61329,"source":{"system":"sec-edgar","filing":"0000939767-18-000002","document":"wf-form4_151563042764056.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/939767/000093976718000002/wf-form4_151563042764056.xml","form_type":"4"}},{"id":4102336,"issuer":{"id":3386,"kind":"organization","name":"EXELIXIS, INC."},"owners":[{"id":14410,"kind":"person","name":"Garber Alan M","position":1,"cik":"0001312907","reported_name":"Garber Alan M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-01-11T00:27:21.000Z","date":"2018-01-08","kind":"exercise","acquired":true,"shares":3500,"price":7.97,"value":27895.0,"ownership":{"direct":true},"balance_after":64829,"source":{"system":"sec-edgar","filing":"0000939767-18-000002","document":"wf-form4_151563042764056.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/939767/000093976718000002/wf-form4_151563042764056.xml","form_type":"4"}},{"id":425542,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14410,"kind":"person","name":"Garber Alan M","position":1,"cik":"0001312907","reported_name":"Garber Alan M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2017-06-09T20:07:42.000Z","date":"2017-06-08","kind":"exercise","acquired":true,"shares":5320,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests in 16 quarterly installments from 06/08/2017."}],"balance_after":5320,"derivative":{"exercise_price":125.11,"expiration_date":"2027-06-07","underlying":"Common Stock","underlying_shares":5320},"source":{"system":"sec-edgar","filing":"0001209191-17-038859","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919117038859/doc4.xml","form_type":"4"}},{"id":425541,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14410,"kind":"person","name":"Garber Alan M","position":1,"cik":"0001312907","reported_name":"Garber Alan M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-06-09T20:07:42.000Z","date":"2017-06-08","kind":"grant","acquired":true,"shares":2199,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Restricted stock unit award that vests in four annual installments from 6/08/2017."}],"balance_after":2199,"source":{"system":"sec-edgar","filing":"0001209191-17-038859","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919117038859/doc4.xml","form_type":"4"}},{"id":4303677,"issuer":{"id":3386,"kind":"organization","name":"EXELIXIS, INC."},"owners":[{"id":14410,"kind":"person","name":"Garber Alan M","position":1,"cik":"0001312907","reported_name":"Garber Alan M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option (right to buy)","published_at":"2017-05-27T00:47:34.000Z","date":"2017-05-25","kind":"grant","acquired":true,"shares":23491,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Option granted pursuant to the Exelixis, Inc. 2017 Equity Incentive Plan. The option is exercisable immediately, subject to repurchase provisions, and will vest as to 1/12th of the shares subject to the option each month following the date of grant, subject to the Reporting Person's continuous service through such dates."}],"balance_after":23491,"derivative":{"exercise_price":19.57,"exercise_date":"2017-05-25","expiration_date":"2024-05-24","underlying":"Common Stock","underlying_shares":23491},"source":{"system":"sec-edgar","filing":"0000939767-17-000110","document":"wf-form4_149584603869354.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/939767/000093976717000110/wf-form4_149584603869354.xml","form_type":"4"}},{"id":4527532,"issuer":{"id":3386,"kind":"organization","name":"EXELIXIS, INC."},"owners":[{"id":14410,"kind":"person","name":"Garber Alan M","position":1,"cik":"0001312907","reported_name":"Garber Alan M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option (right to buy)","published_at":"2016-12-10T01:02:17.000Z","date":"2016-12-09","kind":"exercise","acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option, representing the right to purchase a total of 10,000 shares of Exelixis, Inc. common stock, became fully exercisable on May 2, 2008."}],"balance_after":0,"derivative":{"exercise_price":10.53,"exercise_date":"2008-05-02","expiration_date":"2017-05-01","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0000939767-16-000290","document":"wf-form4_148133172396557.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/939767/000093976716000290/wf-form4_148133172396557.xml","form_type":"4"}},{"id":4527531,"issuer":{"id":3386,"kind":"organization","name":"EXELIXIS, INC."},"owners":[{"id":14410,"kind":"person","name":"Garber Alan M","position":1,"cik":"0001312907","reported_name":"Garber Alan M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2016-12-10T01:02:17.000Z","date":"2016-12-09","kind":"sale","acquired":false,"shares":7832,"price":16.9,"value":132360.8,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $16.9001 to $16.9006. Reporting person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 2 to this Form 4."}],"balance_after":61329,"source":{"system":"sec-edgar","filing":"0000939767-16-000290","document":"wf-form4_148133172396557.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/939767/000093976716000290/wf-form4_148133172396557.xml","form_type":"4"}},{"id":4527530,"issuer":{"id":3386,"kind":"organization","name":"EXELIXIS, INC."},"owners":[{"id":14410,"kind":"person","name":"Garber Alan M","position":1,"cik":"0001312907","reported_name":"Garber Alan M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2016-12-10T01:02:17.000Z","date":"2016-12-09","kind":"exercise","acquired":true,"shares":10000,"price":10.53,"value":105300.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 2,638 shares of Exelixis, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units."}],"balance_after":69161,"source":{"system":"sec-edgar","filing":"0000939767-16-000290","document":"wf-form4_148133172396557.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/939767/000093976716000290/wf-form4_148133172396557.xml","form_type":"4"}}]}